Home โบ Breast Cancer โบ Utah
Breast Cancer clinical trials in Utah
42 studies for Breast Cancer are looking for participants at sites in Utah.
Cities in Utah
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
- Research Facility, Salt Lake City
RecruitingPhase 1/2
All ages ยท All sexes ยท Updated Nov 12, 2026 ยท NCT06590857A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Intermountain Medical Center ( Site 0074), Murray
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Nov 10, 2026 ยท NCT06966700A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- South Texas Accelerated Research Therapeutics (START) Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Nov 5, 2026 ยท NCT07029399A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Nov 5, 2026 ยท NCT07318805Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
- Huntsman Cancer Institute, University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Nov 5, 2026 ยท NCT06982521A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- Utah Cancer Specialists, Salt Lake City
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Nov 4, 2026 ยท NCT07174336A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
- Huntsman Cancer Hospital at the University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Nov 4, 2026 ยท NCT06790693A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 2
Ages 18 and older ยท Women ยท Updated Nov 4, 2026 ยท NCT07287098Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- START Mountain Region, West Valley City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Nov 4, 2026 ยท NCT05579366A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Nov 4, 2026 ยท NCT06400472Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
- Farmington Health Center, Farmington
- University of Utah Sugarhouse Health Center, Salt Lake City
- Huntsman Cancer Institute/University of Utah, Salt Lake City
- and 1 more
RecruitingPhase 3
Ages 18 to 60 ยท Women ยท Updated Nov 4, 2026 ยท NCT05879926A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- Intermountain/LDS Hospital Ph 1 Research Program, Salt Lake City
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Oct 29, 2026 ยท NCT06774963A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- START Center for Cancer Research, West Valley City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Oct 28, 2026 ยท NCT07109726A Study of MGC026 in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Oct 28, 2026 ยท NCT06242470A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
- University of Utah Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Oct 26, 2026 ยท NCT07100106A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
- START Mountain Region, LLC, West Valley City
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Oct 22, 2026 ยท NCT07383506A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
- Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Oct 19, 2026 ยท NCT07062965A Study to Evaluate ATX-898 in Participants With Advanced Solid Tumors
- START Mountain Region Cancer Center, West Valley City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Oct 16, 2026 ยท NCT07767474Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
- START - Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Oct 5, 2026 ยท NCT06784193Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Salt Lake City
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Sep 23, 2026 ยท NCT07085767A Phase 1/1b Study of IAM1363 in HER2 Cancers
- START Mountain Region, West Valley City
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 9, 2026 ยท NCT06253871Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu
- Huntsman Cancer Institute at University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Aug 20, 2026 ยท NCT07203378Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
- Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Aug 17, 2026 ยท NCT06500481Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
- University of Utah - Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 3
Ages 18 to 100 ยท All sexes ยท Updated Aug 6, 2026 ยท NCT05232916First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
- START Mountain Region, West Valley City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Jul 7, 2026 ยท NCT05768139A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Huntsman Cancer Institute, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Jun 29, 2026 ยท NCT05377996I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- Huntsman Cancer Institute, University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated May 6, 2026 ยท NCT01042379Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Recruiting
Ages 18 and older ยท All sexes ยท Updated Apr 30, 2026 ยท NCT05297734De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork
- Sandra L Maxwell Cancer Center, Cedar City
- Logan Regional Hospital, Logan
- and 7 more
RecruitingPhase 3
Ages 50 to 70 ยท All sexes ยท Updated Apr 23, 2026 ยท NCT04852887A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
- START Center for Cancer Care - Mountain Region, Salt Lake City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Mar 27, 2026 ยท NCT06395519Feasibility Evaluation of the Muse Magnetic Resonance Guided Focused Ultrasound System
- Huntsman Cancer Institute at University of Utah, Salt Lake City
RecruitingEarly phase 1
Ages 18 and older ยท Women ยท Updated Mar 17, 2026 ยท NCT05291507Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
- START, Mountain Region, West Valley City
RecruitingPhase 1/2
Ages 18 and older ยท All sexes ยท Updated Feb 17, 2026 ยท NCT07145255Improving Care for Rural Patients With Solid Tumors
- Huntsman Cancer Institute at the University of Utah, Salt Lake City
Recruiting
Ages 18 to 99 ยท All sexes ยท Updated Feb 5, 2026 ยท NCT049169905 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer
- Huntsman Cancer Institute/University of Utah, Salt Lake City
RecruitingPhase 2
Ages 18 and older ยท Women ยท Updated Dec 9, 2025 ยท NCT06961955SAVE Trial: SAfe Opioid Use Video Education
- University of Utah Huntsman Cancer Institute, Salt Lake City
Recruiting
Ages 18 and older ยท Women ยท Updated Nov 26, 2025 ยท NCT07044583Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study
- Huntsman Cancer Institute/ University of Utah, Salt Lake City
RecruitingHealthy volunteers welcome
Ages 18 and older ยท Women ยท Updated Nov 21, 2025 ยท NCT07029490SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Salt Lake City
RecruitingObservational study
All ages ยท All sexes ยท Updated Oct 28, 2025 ยท NCT03452774Guided Meditation During Radiation Therapy for Breast and Gynecological Malignancies
- Huntsman Cancer Institute at University of Utah, Salt Lake City
RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Oct 3, 2025 ยท NCT07166042First-in-Human Study of Mutant-selective PI3Kฮฑ Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
- University of Utah- Huntsman Cancer Center, Salt Lake City
RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Sep 22, 2025 ยท NCT05216432MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- Ogden Regional Cancer Center, Ogden
RecruitingObservational study
Ages 18 and older ยท All sexes ยท Updated Aug 20, 2025 ยท NCT03053193From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.